Your browser doesn't support javascript.
loading
Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia.
Garcia-Portilla, Maria Paz; Llorca, Pierre-Michel; Maina, Giuseppe; Bozikas, Vasilis P; Devrimci-Ozguven, Halise; Kim, Sung-Wan; Bergmans, Paul; Usankova, Irina; Pungor, Katalin.
Afiliação
  • Garcia-Portilla MP; Department of Psychiatry, University of Oviedo, CIBERSAM, Oviedo, Spain.
  • Llorca PM; CMP B, CHU Clermont-Ferrand, Clermont Auvergne University, Clermont-Ferrand, France.
  • Maina G; SCDU Psichiatria, AOU San Luigi Gonzaga, Università degli Studi di Torino, Torino, Piemonte, Italy.
  • Bozikas VP; Second Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Devrimci-Ozguven H; Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.
  • Kim SW; Department of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea.
  • Bergmans P; Janssen Cilag, Biostatistics, Breda, The Netherlands.
  • Usankova I; Johnson & Johnson, EMEA Medical Affairs Organization, Moscow, Russia.
  • Pungor K; EMEA Medical Affairs, Janssen Cilag GmbH, Johnson & Johnson Platz 1, Neuss, 41470, Germany.
Ther Adv Psychopharmacol ; 10: 2045125320926347, 2020.
Article em En | MEDLINE | ID: mdl-32518617

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article